A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma (Q33394736)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma |
scientific article |
Statements
1 reference
A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma (English)
1 reference
John M Kirkwood
1 reference
Rene Gonzalez
1 reference
Douglas Reintgen
1 reference
Philip R Clingan
1 reference
Robert R McWilliams
1 reference
Dinesh P de Alwis
1 reference
Annamaria Zimmermann
1 reference
Robert L Ilaria
1 reference
Michael J Millward
1 reference
31 March 2011
1 reference
1 reference
117
1 reference
20
1 reference
4732-4739
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference